ArticleCancers2023

Evaluation of Anlotinib Combined with Adriamycin and Ifosfamide as Conversion Therapy for Unresectable Soft Tissue Sarcomas.

Zuoyao Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.